CompoAtlas

Multivitamines

Food supplement declared in France, decision dated 24 October 2026

Multivitamines (UPSA) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
UPSA
Food business operator placing the product on the market
UPSA SAS
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Autre : comprimé pelliculé
Daily dose
1 comprimé pelliculé par jour
Directions for use
1 comprimé pelliculé à avaler par jour pendant 30 jours, avec un verre d’eau, de préférence le matin.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Children (under 12), Young children (aged 1 to 3), Infants (under 1 year), Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Autre : Propriétés stimulantes et énergisantes, Système nerveux, Immunité

Declaration 380369, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Hibiscus sabdariffa L.FleurExtrait sec aqueux500 mg

Other active ingredients

NamePer day
Triglycérides à chaine moyennenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
Oxyde de magnésiumMagnésium250 mg300 mg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulled by the French Council of State in 2011
Riboflavine 5'-phosphateVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Sulfate de zincZinc25 mg15 mg

Additives

E460, E341, E463, E470b, E464, E1200, E170, E553b, E122, E132

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l'adulte. Ne pas dépasser la dose journalière recommandée. A consommer dans le cadre d’une alimentation variée et équilibrée et d’un mode de vie sain. Garder hors de portée des enfants. Les femmes enceintes et allaitantes doivent prendre conseil auprès d’un professionnel de santé avant toute complémentation. La carmoisine peut avoir des effets indésirables sur l’activité et l’attention chez les enfants. A conserver à l’abri de la lumière, de la chaleur (< 25°C) et de l’humidité.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : UPSA

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line